Sven Ante Lundberg
Net Worth

Last updated:

What is Sven Ante Lundberg net worth?

The estimated net worth of Dr. Sven Ante Lundberg is at least $6,553,476 as of 3 Nov 2022. He owns shares worth $2,606,196 as insider and has received compensation worth at least $3,947,280 in Merus N.V..

What is the salary of Sven Ante Lundberg?

Dr. Sven Ante Lundberg salary is $986,820 per year as Chief Executive Officer, Pres, Principal Financial Officer & Executive Director in Merus N.V..

How old is Sven Ante Lundberg?

Dr. Sven Ante Lundberg is 62 years old, born in 1963.

What stocks does Sven Ante Lundberg currently own?

As insider, Dr. Sven Ante Lundberg owns shares in one company:

Company Title Shares Price per share Total value
Merus N.V. (MRUS) Chief Executive Officer, Pres, Principal Financial Officer & Executive Director 40,576 $64.23 $2,606,196

What does Merus N.V. do?

Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.

MRUS logo
MRUS
Merus N.V.
$64.23

Sven Ante Lundberg insider trading

Merus N.V.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Shares 14,706 $14.38 $211,428
Purchase
Common Stock 5,826 $22.93 $133,561
Purchase
Common Stock 704 $22.99 $16,187
Purchase
Common Shares 4,340 $22.97 $99,685
Option
Share Option (right to buy) 15,000 $13.03 $195,450
Option
Common Shares 15,000 $13.03 $195,450
Option
Share Option (right to buy) 74,000 $13.03 $964,220
Option
Common Shares 74,000 $13.03 $964,220
Option
Common Shares 74,000 $13.03 $964,220
Option
Share Option (right to buy) 74,000 $13.03 $964,220

Merus N.V. key executives

Merus N.V. executives and other stock owners filed with the SEC:

  • Dr. Sven Ante Lundberg (62) Chief Executive Officer, Pres, Principal Financial Officer & Executive Director
  • Mr. Hui Liu (58) Chief Bus. Officer, Executive Vice President & Head of Merus U.S.
  • Mr. Peter B. Silverman J.D. (47) Executive Vice President, Gen. Counsel, Chief Intellectual Property Officer and Head of Utrecht & US Legal